| Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter PA Volberding, SW Lagakos, MA Koch, C Pettinelli, MW Myers, DK Booth, ... New England Journal of Medicine 322 (14), 941-949, 1990 | 1543 | 1990 |
| Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the … F Van Leth, P Phanuphak, K Ruxrungtham, E Baraldi, S Miller, B Gazzard, ... The Lancet 363 (9417), 1253-1263, 2004 | 886 | 2004 |
| Class-sparing regimens for initial treatment of HIV-1 infection SA Riddler, R Haubrich, AG DiRienzo, L Peeples, WG Powderly, ... New England Journal of Medicine 358 (20), 2095-2106, 2008 | 867 | 2008 |
| Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection RM Gulick, HJ Ribaudo, CM Shikuma, S Lustgarten, KE Squires, ... New England Journal of Medicine 350 (18), 1850-1861, 2004 | 708 | 2004 |
| Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection GK Robbins, V De Gruttola, RW Shafer, LM Smeaton, SW Snyder, ... New England Journal of Medicine 349 (24), 2293-2303, 2003 | 473 | 2003 |
| High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ... Journal of Infectious Diseases 171 (3), 537-545, 1995 | 385 | 1995 |
| Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical … FJ Torriani, L Komarow, RA Parker, BR Cotter, JS Currier, MP Dubé, ... Journal of the American College of Cardiology 52 (7), 569-576, 2008 | 350 | 2008 |
| Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 F Van Leth, P Phanuphak, E Stroes, B Gazzard, P Cahn, F Raffi, R Wood, ... PLoS medicine 1 (1), e19, 2004 | 339 | 2004 |
| Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile M van der Valk, JJP Kastelein, RL Murphy, F van Leth, C Katlama, ... Aids 15 (18), 2407-2414, 2001 | 326 | 2001 |
| Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus P Pertel, R Hirschtick, J Phair, J Chmiel, L Poggensee, R Murphy JAIDS Journal of Acquired Immune Deficiency Syndromes 5 (11), 1069-1074, 1992 | 324 | 1992 |
| The significance of longitudinal excursion in peripheral nerves EFS Wilgis, R Murphy Hand clinics 2 (4), 761-766, 1986 | 309 | 1986 |
| ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results RL Murphy, S Brun, C Hicks, JJ Eron, R Gulick, M King, AC White Jr, ... Aids 15 (1), F1-F9, 2001 | 302 | 2001 |
| Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia JE Beal, R Olson, L Lefkowitz, L Laubenstein, P Bellman, B Yangco, ... Journal of Pain and Symptom Management 14 (1), 7-14, 1997 | 302 | 1997 |
| Three-vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial RM Gulick, HJ Ribaudo, CM Shikuma, C Lalama, BR Schackman, ... Jama 296 (7), 769-781, 2006 | 290 | 2006 |
| The history of antiretroviral therapy and of its implementation in resource-limited areas of the world S Vella, B Schwartländer, SP Sow, SP Eholie, RL Murphy Aids 26 (10), 1231-1241, 2012 | 286 | 2012 |
| Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients C Duvivier, S Kolta, L Assoumou, J Ghosn, S Rozenberg, RL Murphy, ... Aids 23 (7), 817-824, 2009 | 278 | 2009 |
| The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults JM Kilby, JP Lalezari, JJ Eron, M Carlson, C Cohen, RC Arduino, ... AIDS research and human retroviruses 18 (10), 685-693, 2002 | 272 | 2002 |
| A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients R Van Leeuwen, C Katlama, RL Murphy, K Squires, J Gatell, A Horban, ... Aids 17 (7), 987-999, 2003 | 266 | 2003 |
| Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial J Kahn, S Lagakos, M Wulfsohn, D Cherng, M Miller, J Cherrington, ... Jama 282 (24), 2305-2312, 1999 | 266 | 1999 |
| Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis J Musa, CJ Achenbach, LC O’Dwyer, CT Evans, M McHugh, L Hou, ... PloS one 12 (9), e0183924, 2017 | 236 | 2017 |
